• Journal of mucopolysaccharidosis and rare diseases
• /
• 제2권1호
• /
• pp.28-28
• /
• 2016

• Journal of mucopolysaccharidosis and rare diseases
• /
• 제2권1호
• /
• pp.32-32
• /
• 2016

• Journal of mucopolysaccharidosis and rare diseases
• /
• 제2권1호
• /
• pp.29-30
• /
• 2016

• Journal of mucopolysaccharidosis and rare diseases
• /
• 제2권1호
• /
• pp.33-33
• /
• 2016

• Journal of mucopolysaccharidosis and rare diseases
• /
• 제2권1호
• /
• pp.34-34
• /
• 2016

• Clinics in Shoulder and Elbow
• /
• 제19권1호
• /
• pp.20-24
• /
• 2016

Background: Extracorporeal shock wave therapy (ESWT) is one of the treatment options used for patients with myofascial pain syndrome (MPS), although its effectiveness is controversial. The purpose of this study was to evaluate the effectiveness of ESWT in the treatment of MPS in terms of pain relief and functional improvements. Methods: We assessed 93 patients with MPS who underwent ESWT from March 2009 to July 2014. After exclusion of 25 patients with shoulder diseases, 68 patients were enrolled in the study. The mean follow-up period was 7.5 months (${\pm}4.2weeks$), and the average duration of symptoms was 5 months (range, 2-16 months). ESWT was applied to intramuscular taut bands and referred pain areas once a week for 3 weeks. Visual analog scale (VAS) pain scores and American Shoulder and Elbow Surgeons (ASES) scores were obtained at an initial assessment and at the 6-week, 3-month, and 6-month follow-up assessments. Results: VAS pain scores and ASES scores improved significantly after 3 sessions of ESWT (p<0.05). Both scores were improved, although not significantly, after 6 weeks (p>0.05). Conclusions: ESWT is an effective treatment option for patients with MPS.

• Journal of Korean Medical Science
• /
• 제33권52호
• /
• pp.337.1-337.14
• /
• 2018

Background: Mitochondrial heteroplasmy, the co-existence of different mitochondrial polymorphisms within an individual, has various forensic and clinical implications. But there is still no guideline on the application of massively parallel sequencing (MPS) in heteroplasmy detection. We present here some critical issues that should be considered in heteroplasmy studies using MPS. Methods: Among five samples with known innate heteroplasmies, two pairs of mixture were generated for artificial heteroplasmies with target minor allele frequencies (MAFs) ranging from 50% to 1%. Each sample was amplified by two-amplicon method and sequenced by Ion Torrent system. The outcomes of two different analysis tools, Torrent Suite Variant Caller (TVC) and mtDNA-Server (mDS), were compared. Results: All the innate heteroplasmies were detected correctly by both analysis tools. Average MAFs of artificial heteroplasmies correlated well to the target values. The detection rates were almost 90% for high-level heteroplasmies, but decreased for low-level heteroplasmies. TVC generally showed lower detection rates than mDS, which seems to be due to their own computation algorithms which drop out some reference-dominant heteroplasmies. Meanwhile, mDS reported several unintended low-level heteroplasmies which were suggested as nuclear mitochondrial DNA sequences. The average coverage depth of each sample placed on the same chip showed considerable variation. The increase of coverage depth had no effect on the detection rates. Conclusion: In addition to the general accuracy of the MPS application on detecting heteroplasmy, our study indicates that the understanding of the nature of mitochondrial DNA and analysis algorithm would be crucial for appropriate interpretation of MPS results.

• 대한임상전기생리학회지
• /
• 제2권1호
• /
• pp.1-8
• /
• 2004

This study was conducted to assess the effect of transcutaneous electrical nerve stimulation(TENS) and interferential current(IFC) in the patients with myofascial pain syndrome(MPS) on upper trapezius. Twenty patients with MPS on upper trapezius was assigned randomly to TENS group(n=10), IFC group(n=10). In TENS group, TENS was applied to the trigger point. In IFC group, IFC was applied to the trigger point. Duration of treatment was 2 weeks. Effects were assessed before treatment, post treatment by visual analogue scale(VAS), and pain rating score(PRS). Significant change of VAS was noticed in TENS group and IFC group. Significant change of PRS was noticed in TENS group and IFC group. IFC groups were significantly higher than TENS group that of the VAS and PRS. These result showed that IFC is effective treatment method for pain control in patients with MPS.

• International Journal of Naval Architecture and Ocean Engineering
• /
• 제13권1호
• /
• pp.575-584
• /
• 2021

This study contains the process of developing a Mission Planning System (MPS) of an USV that can be applied in real situations and verifying them through HILS. In this study, we set the scenario of a single USV with limited operating time. Since the USV may not perform some missions due to the limited operating time, an objective function was defined to maximize the Mission Achievement Rate (MAR). We used a genetic algorithm to solve the problem model, and proposed a method using a 3-D population. The simulation showed that the probability of deriving the global optimal solution of the mission planning algorithm was 96.6% and the computation time was 1.6 s. Furthermore, USV showed it performs the mission according to the results of the MPS. We expect that the MPS developed in this study can be applied to the real environment where USV performs missions with limited time conditions.

• Nuclear Medicine and Molecular Imaging
• /
• 제42권5호
• /
• pp.354-361
• /
• 2008

목적: 암모니아의 심근섭취는 심근의 관류나 생존능 및 대사에 관계되어 있으며, N-13 암모니아 PET은 심근의 허혈을 진단하는 데에 유용한 것으로 알려져 있다. 그러나, 아데노신을 이용한 약물부하 심근관류 검사로 N-13 암모니아 PET/CT와 Tc-99m 세스타미비 SPECT 검사를 비교한 연구는 없었다. 이 연구에서는 관상동맥질환이 의심되는 환자에게서 아데노신 약물부하로 N-13 암모니아 PET/CT와 Tc-99m 세스타미비 SPECT를 시행하여 두 검사의 차이를 비교분석하여 N-13 암모니아 PET/CT의 임상 유용성을 알아보았다. 대상 및 방법: 관상동맥질환이 의심되는 환자 중 Tc-99m 세스타미비 SPECT와 N-13 암모니아 PET/CT를 동시에 시행할 수 있었고, 검사 1주일 이내 관상동맥조영술을 시행하였던 17명의 환자(남자:13명, 평균연령 $63{\pm}11$세)를 대상으로 하였다. 아데노신약물 부하 후 N-13 암모니아 PET/CT와 Tc-99m 세스타미비를 검사하여 육안 분석과 정량분석을 실시하였다. 결과: 관상동맥조영술에서 50% 이상의 협착이 확인된 관상동맥의 진단에 대한 민감도와 특이도는 N-13 암모니아 PET/CT는 91%와 89%로, Tc-99m세스타미비 SPECT는 65%와 82%로 각각 나타났다. 또한 N-13 암모니아 PET/CT와 Tc-99m 세스타미비 SPECT는 전체에 238분절 중 65%인 154분절에서 동일한 결과를 보였으며, N-13 암모니아 PET/CT는 Tc-99m 세스타미비 SPECT에서 비가역적인 관류결손을 보였던 병변 중 54%에 대하여 가역적인 관류결손을 나타내었다. 협착혈관이 관장하는 심근부위에 해당하는 110개의 분절에 대하여 부하기와 휴식기의 계수를 N-13 암모니아 PET/CT와 Tc-99m세스타미비 SPECT에서 각각 비교하였을 때, 부하기의 비교에서는, 두 검사간에 유의한 차이를 보이지 않았으나, 휴식기에서는 N-13 암모니아 PET/CT의 계수가 Tc-99m세스타미비 SPECT의 계수보다 높았으며 (p<0.01), 휴식기와 부하기의 계수의 차이도 N-13 암모니아 PET/CT가 Tc-99m 세스타미비 SPECT보다 큰 것으로 나타났다(p<0.01). 결론: N-13 암모니아 PET/CT는 Tc-99m 세스타미비 SPECT보다 관상동맥질환의 진단이 정확하고, 가역적인 관류결손을 보인 분절의 수가 많으며, 휴식-부하 관류차이도 현저하여, 관상동맥질환의 정확한 진단과 함께 심근의 허혈이나 생존능을 더욱 잘 반영하는 것으로 사료된다.